MedTrace Logo

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

NCT04134169 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2022-10-10

No results posted yet for this study

Summary

Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)

Conditions

Interventions

OTHER

Not applicable(observational study)

Not applicable(observational study)

Sponsors & Collaborators

  • Kang Stem Biotech Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-02
Primary Completion
2025-08-11
Completion
2026-04-11

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04134169 on ClinicalTrials.gov